An AICD continuously senses intracardiac electrical activity to detect malignant ventricular arrhythmias. When ventricular tachycardia or ventricular fibrillation is identified, it delivers antitachycardia pacing or a high-energy shock to restore normal rhythm. It does not improve contractility but prevents sudden cardiac death by rapid arrhythmia termination.
AICD is indicated for secondary prevention in survivors of cardiac arrest or sustained VT/VF not due to reversible causes, and for primary prevention in patients with LVEF β€35% due to ischemic or non-ischemic cardiomyopathy on optimal medical therapy, typically NYHA class IIβIII. It significantly reduces arrhythmia related mortality.
π +91-9438181786βοΈ acharyaritesh1987@gmail.comπ MonβFri: 10:00 AM β 08:00 PM
Electrophysiology study & RF ablation (2D & 3D mapping)
Dual chamber pacemaker & ICD implantation
Coronary angiogram & angioplasty
Peripheral angiogram & pericardiocentesis
Conduction system pacing & CRT implantation
PTMC, TAVI, ASD, VSD & PDA closure
2D & Colour Doppler Echocardiography
Biodata
Dr. Ritesh Acharya is a highly trained Cardiologist and Electrophysiologist with
extensive experience in advanced cardiac electrophysiology, device therapy, and
coronary interventions.
His academic background includes training at SCB Medical College, KIMS Bhubaneswar,
and a Post Doctoral Fellowship in Cardiac Electrophysiology from Medicover Hospital,
Hyderabad.
He has multiple national and international publications including articles in
New England Journal of Medicine, Indian Heart Journal, and CSI Update.
He is an active participant and presenter at IHRS, CSI, and APICON conferences.